European stocks sink as vaccine optimism fades
Unemployment: London job market lags
Global equities ran out of steam as vaccine and Biden jubilation fade
“Equities have moved lower this morning, as the vaccine bounce begins to fade across markets. After days of gains the rally in equities is beginning to slow down, as indices throughout Europe move into the red.”
“As enthusiasm about a vaccine begins to fade the FTSE 100 has lost ground, with a slowdown in the excited buying of hard-hit value names in sectors like travel, airlines, banks and others.”
Having soared on Monday, Rolls Royce has spent a few days shedding points, down by an additional 8% on Thursday. Similarly, having enjoyed an escape from a difficult year so far this week, oil blue chips such as BP and Shell followed the path of airlines, and watched their shares fall. Another issue has been a lack of positive developments – which is giving markets mixed messages. Mr Beauchamp added: “Political developments, or lack thereof, continue to have little impact, with the lack of any White House pronouncements helping to calm market nerves about the US political outlook.” Spreadex Financial Analyst, Connor Campbell, added on Brexit: “The mid-November deal deadline is almost upon us, with no agreement in site, and Boris Johnson’s government internally in chaos after the departure of director of communications, and Dominic Cummings ally, Lee Cain.” With global equities lacking a reason to celebrate, Eurozone indexes slipped, with the DAX down 1.2% and the CAC falling 1.5%. Slightly ahead of its European counterparts, the FTSE fell by 0.7%, lifted slightly by a sharp drop-off in Sterling. Notably, the Dow Jones was down by over 1.3%, and the Nasdaq fell by 0.8%. Even with vaccine jubilation fading – which should favour 2020’s growth stocks – big tech couldn’t muster up enough strength to lift US markets.Living for the long term…Mainstream Impact Investment and Emerging Market Strategies are breaking the mould
GVC Holdings sets out its strategy for conscientious gambling
QinetiQ shares rise on revenue growth
National Express posts growing revenue ahead of second lockdown
Vistry reinstates dividend on strong demand
The new vaccine chapter for value stocks and COVID-19 shares
The UK Investor Magazine Podcast is joined by Alan Green for a run down of the dramatic moves in markets this week and exploration of scenarios going into the end of 2020.
The Biden Presidential victory has been overshadowed by news from Pfizer had a breakthrough in the fight against COVID-19 with a vaccine demonstrating 90% effectiveness. We look at the sharp rally in markets and question the sustainability going forward.
We discuss Novacyt (NCYT), Synairgen (SNG), Avacta (AVCT), Blue Prism (PRSM) and Capita (CPI).
